United Therapeutics Corporation
TREATMENT FOR INTERSTITIAL LUNG DISEASE
Last updated:
Abstract:
Methods of treating of interstitial lung disease, reducing pulmonary function decline in a subject with interstitial lung disease (ILD), and increasing forced vital capacity (FVC) in a subject suffering from ILD are provided, wherein the methods include administration of treprostinil.
Status:
Application
Type:
Utility
Filling date:
16 Apr 2021
Issue date:
28 Oct 2021